| Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls (NCT05393076) | GlaxoSmithKline | 2022-07-19 |
| Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE) (NCT04965636) | GlaxoSmithKline | 2022-07-14 |
| Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (NCT05263934) | GlaxoSmithKline | 2022-07-14 |
| Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19 (NCT05305651) | GlaxoSmithKline | 2022-07-01 |
| A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants (NCT05412030) | GlaxoSmithKline | 2022-06-16 |
| Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma (NCT05398198) | GlaxoSmithKline | 2022-06-09 |
| Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections (NCT05138822) | GlaxoSmithKline | 2022-05-18 |
| Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions (NCT05811754) | GlaxoSmithKline | 2022-05-09 |
| Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India (NCT04600752) | GlaxoSmithKline | 2022-05-07 |
| Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (NCT05274750) | GlaxoSmithKline | 2022-04-22 |
| A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions (NCT04964050) | GlaxoSmithKline | 2022-04-21 |
| Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2) (NCT05281523) | GlaxoSmithKline | 2022-04-18 |
| Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection (NCT05330455) | GlaxoSmithKline | 2022-04-14 |
| Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants (NCT05260437) | GlaxoSmithKline | 2022-03-24 |
| First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors (NCT05277051) | GlaxoSmithKline | 2022-03-22 |
| A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy (NCT05276297) | GlaxoSmithKline | 2022-03-22 |
| A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy (NCT05229068) | GlaxoSmithKline | 2022-03-11 |
| A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes (NCT05298254) | GlaxoSmithKline | 2022-03-07 |
| Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma (NCT05064358) | GlaxoSmithKline | 2022-03-03 |
| An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) (NCT05243680) | GlaxoSmithKline | 2022-03-01 |
| A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants (NCT05271799) | GlaxoSmithKline | 2022-03-01 |
| Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions (NCT04878315) | GlaxoSmithKline | 2022-02-13 |
| All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma (NCT06956170) | GlaxoSmithKline | 2022-02-10 |
| A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age (NCT05084508) | GlaxoSmithKline | 2022-02-03 |
| A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India (NCT05219253) | GlaxoSmithKline | 2022-02-02 |
| Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials (NCT05100316) | GlaxoSmithKline | 2021-12-16 |
| Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19 (NCT05124210) | GlaxoSmithKline | 2021-12-16 |
| Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) (NCT04954859) | GlaxoSmithKline | 2021-12-14 |
| Study of GSK3511294 in Healthy Chinese Participants (NCT05140200) | GlaxoSmithKline | 2021-12-10 |
| A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants (NCT05082285) | GlaxoSmithKline | 2021-11-29 |
| Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants (NCT05133830) | GlaxoSmithKline | 2021-11-23 |
| Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents (NCT05087056) | GlaxoSmithKline | 2021-11-18 |
| Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis (NCT04975438) | GlaxoSmithKline | 2021-11-18 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants (NCT05131971) | GlaxoSmithKline | 2021-11-01 |
| A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. (NCT05045144) | GlaxoSmithKline | 2021-10-26 |
| Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) (NCT04908865) | GlaxoSmithKline | 2021-10-21 |
| A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults (NCT05089630) | GlaxoSmithKline | 2021-10-14 |
| A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine (NCT05047770) | GlaxoSmithKline | 2021-10-07 |
| A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants (NCT05073003) | GlaxoSmithKline | 2021-10-06 |
| A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above (NCT05059301) | GlaxoSmithKline | 2021-10-01 |
| A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants (NCT05044325) | GlaxoSmithKline | 2021-09-20 |
| Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis (NCT04971590) | GlaxoSmithKline | 2021-09-14 |
| Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment (NCT04971928) | GlaxoSmithKline | 2021-09-07 |
| Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) (NCT04950127) | GlaxoSmithKline | 2021-08-27 |
| A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers (NCT04980391) | GlaxoSmithKline | 2021-08-03 |
| Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma (NCT04937387) | GlaxoSmithKline | 2021-07-29 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM (NCT07217184) | GlaxoSmithKline | 2021-07-29 |
| China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (NCT06868654) | GlaxoSmithKline | 2021-07-28 |
| Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (NCT06868667) | GlaxoSmithKline | 2021-07-28 |
| Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma (NCT04276233) | GlaxoSmithKline | 2021-06-29 |
| Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease (NCT04915755) | GlaxoSmithKline | 2021-06-28 |
| A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults (NCT04886154) | GlaxoSmithKline | 2021-06-14 |
| An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe. (NCT04950712) | GlaxoSmithKline | 2021-06-09 |
| Molecular Disease Characterization Initiative (MDCI) (NCT04772053) | GlaxoSmithKline | 2021-05-25 |
| Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above (NCT04886596) | GlaxoSmithKline | 2021-05-25 |
| Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years (NCT04869982) | GlaxoSmithKline | 2021-05-14 |
| A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above (NCT04841577) | GlaxoSmithKline | 2021-04-27 |
| Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China (NCT04853238) | GlaxoSmithKline | 2021-04-27 |
| A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function (NCT04398680) | GlaxoSmithKline | 2021-04-20 |
| A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study (NCT04641247) | GlaxoSmithKline | 2021-04-16 |
| Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype (NCT04719832) | GlaxoSmithKline | 2021-03-17 |
| A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older (NCT04789577) | GlaxoSmithKline | 2021-03-16 |
| Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM (NCT06655818) | GlaxoSmithKline | 2021-03-09 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 (NCT06790303) | GlaxoSmithKline | 2021-03-04 |
| Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms (NCT04749459) | GlaxoSmithKline | 2021-03-03 |
| Substance P Challenge in Healthy Participants (NCT04676763) | GlaxoSmithKline | 2021-03-02 |
| A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years (NCT04762511) | GlaxoSmithKline | 2021-03-02 |
| Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above (NCT04732871) | GlaxoSmithKline | 2021-02-15 |
| A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults (NCT04758962) | GlaxoSmithKline | 2021-02-15 |
| A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Bicarbonate and Sodium Hyaluronate on Gingivitis (NCT04737538) | GlaxoSmithKline | 2021-02-10 |
| Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) (NCT04607005) | GlaxoSmithKline | 2021-02-08 |
| A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype (NCT04718103) | GlaxoSmithKline | 2021-02-04 |
| Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) (NCT04676724) | GlaxoSmithKline | 2021-01-28 |
| A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NCT04718389) | GlaxoSmithKline | 2021-01-26 |
| Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine (NCT04707391) | GlaxoSmithKline | 2021-01-25 |
| Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants (NCT04657211) | GlaxoSmithKline | 2021-01-14 |
| Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin (NCT04549363) | GlaxoSmithKline | 2020-12-21 |
| Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants (NCT04640311) | GlaxoSmithKline | 2020-12-18 |
| Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan (NCT04551989) | GlaxoSmithKline | 2020-12-11 |
| Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants (NCT04311463) | GlaxoSmithKline | 2020-12-09 |
| Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study (NCT04657198) | GlaxoSmithKline | 2020-12-09 |
| Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy (NCT04655976) | GlaxoSmithKline | 2020-12-08 |
| A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers (NCT04605159) | GlaxoSmithKline | 2020-11-20 |
| Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (NCT04581824) | GlaxoSmithKline | 2020-11-19 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole (NCT04604795) | GlaxoSmithKline | 2020-11-04 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants (NCT04472897) | GlaxoSmithKline | 2020-10-30 |
| Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NCT04475939) | GlaxoSmithKline | 2020-10-26 |
| A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer (NCT04349280) | GlaxoSmithKline | 2020-10-15 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. (NCT04557371) | GlaxoSmithKline | 2020-10-12 |
| A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function (NCT04398745) | GlaxoSmithKline | 2020-10-09 |
| Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) (NCT04544995) | GlaxoSmithKline | 2020-10-06 |
| A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B (NCT04544956) | GlaxoSmithKline | 2020-10-06 |
| A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture Adhesive (NCT04473521) | GlaxoSmithKline | 2020-10-04 |
| Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma (NCT04484623) | GlaxoSmithKline | 2020-10-01 |
| Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants (NCT04504435) | GlaxoSmithKline | 2020-09-29 |
| A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants (NCT04316585) | GlaxoSmithKline | 2020-09-28 |
| Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age (NCT04318548) | GlaxoSmithKline | 2020-08-25 |
| Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants. (NCT04488770) | GlaxoSmithKline | 2020-08-24 |
| Drug-drug Interaction Study of Gepotidacin (NCT04493931) | GlaxoSmithKline | 2020-08-14 |
| Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults (NCT04502693) | GlaxoSmithKline | 2020-08-14 |